What I have changed my mind about and why
Publication Date
1-6-2023
Abstract
This paper is based upon a panel discussion “What I Have Changed My Mind About and Why” held on 5 November in New Orleans, Louisiana (USA), as part of the ISTSS 2015 annual meeting “Back to Basics: Integrating Clinical and Scientific Knowledge to Advance the Field of Trauma.” The panel was chaired by Professor Dr. Rachel Yehuda of the Icahn School of Medicine at Mount Sinai and the James J. Peters Veterans Affairs, and included five clinician-scholars who exchanged thoughts about what they have changed their minds about over the years: Dr. David Spiegel, Dr. Steven Southwick, Dr. Lori Davis, Dr. Thomas Neylan, and Dr. John Krystal. This paper provides a summary of the salient points made by each expert and the questions and discussion that ensured. Major issues raised included the increasingly clear limitations to the fear-based model that has advanced the field. While treatments for PTSD have improved, there are some aspects of trauma exposure that cannot be entirely repaired. Research providing an evidence base to treatment has led to overly specific treatment guidelines that may obscure more general principles of effective treatment. Treatment might be viewed as a way to increase the plasticity of the brain in the context of processing social cues. A variety of novel and integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, enhancing well-being and resilience, and medications with novel mechanisms, such as ketamine. The fear-based model has advanced the field but has clear limitations. There is a fundamental existential component to trauma that affects both patients and therapists. Integrative therapies include comprehensive holistic care, exercise, returning to competitive work, logotherapy, mindfulness, and enhancing well-being and resilience. Novel and promising therapies include medications like ketamine. It is important that we put new treatments to the test to prove that they work but not become overly specific in identifying treatment methods.
Keywords
Medicine, Pharmacology, Biotechnology, Evolutionary Biology, FOS: Biological sciences, 59999 Environmental Sciences not elsewhere classified, FOS: Earth and related environmental sciences, Ecology, Science Policy, 110309 Infectious Diseases, FOS: Health sciences, Plant Biology
Repository
figshare
Distribution License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Access Instructions and Link
This data is available under the CC-BY 4.0 License
